Enalapril/ Felodipine

Revision as of 02:35, 6 May 2014 by ShiSheng (talk | contribs) (Created page with "{{DrugProjectFormSinglePage |authorTag={{SS}} |genericName=Enalapril/ Felodipine |aOrAn=an |drugClass=Angiotensin Converting Enzyme Inhibitor and Calcium Channel Blocker |blac...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Enalapril/ Felodipine
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Overview

Enalapril/ Felodipine is an Angiotensin Converting Enzyme Inhibitor and Calcium Channel Blocker that is FDA approved for the {{{indicationType}}} of {{{indication}}}. Common adverse reactions include {{{adverseReactions}}}.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

Condition 1

  • Dosing Information
(Dosage)

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

Condition 1

  • Developed by: (Organization)
  • Class of Recommendation: (Class) (Link)
  • Strength of Evidence: (Category A/B/C) (Link)
  • Dosing Information/Recommendation
  • (Dosage)

Non–Guideline-Supported Use

Condition 1

  • Dosing Information
  • There is limited information about Off-Label Non–Guideline-Supported Use of Enalapril/ Felodipine in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

Condition 1

  • Dosing Information
(Dosage)

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

Condition 1

  • Developed by: (Organization)
  • Class of Recommendation: (Class) (Link)
  • Strength of Evidence: (Category A/B/C) (Link)
  • Dosing Information/Recommendation
  • (Dosage)

Non–Guideline-Supported Use

Condition 1

  • Dosing Information
  • There is limited information about Off-Label Non–Guideline-Supported Use of Enalapril/ Felodipine in pediatric patients.

Contraindications

  • Condition 1
  • Condition 2
  • Condition 3
  • Condition 4
  • Condition 5

Warnings

Conidition 1

(Description)

Adverse Reactions

Clinical Trials Experience

Central Nervous System

(list/description of adverse reactions)

Cardiovascular

(list/description of adverse reactions)

Respiratory

(list/description of adverse reactions)

Gastrointestinal

(list/description of adverse reactions)

Hypersensitive Reactions

(list/description of adverse reactions)

Miscellaneous

(list/description of adverse reactions)

Postmarketing Experience

Central Nervous System

(list/description of adverse reactions)

Cardiovascular

(list/description of adverse reactions)

Respiratory

(list/description of adverse reactions)

Gastrointestinal

(list/description of adverse reactions)

Hypersensitive Reactions

(list/description of adverse reactions)

Miscellaneous

(list/description of adverse reactions)

Drug Interactions

  • (Drug 1)
  • (Description)
  • (Drug 2)
  • (Description)
  • (Drug 3)
  • (Description)

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA): There is no FDA guidance on usage of Enalapril/ Felodipine in women who are pregnant.
Pregnancy Category (AUS): There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Enalapril/ Felodipine in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Enalapril/ Felodipine during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Enalapril/ Felodipine in women who are nursing.

Pediatric Use

There is no FDA guidance on the use of Enalapril/ Felodipine in pediatric settings.

Geriatic Use

There is no FDA guidance on the use of Enalapril/ Felodipine in geriatric settings.

Gender

There is no FDA guidance on the use of Enalapril/ Felodipine with respect to specific gender populations.

Race

There is no FDA guidance on the use of Enalapril/ Felodipine with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Enalapril/ Felodipine in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Enalapril/ Felodipine in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Enalapril/ Felodipine in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Enalapril/ Felodipine in patients who are immunocompromised.

Administration and Monitoring

Administration

There is limited information regarding Enalapril/ Felodipine Administration in the drug label.

Monitoring

There is limited information regarding Enalapril/ Felodipine Monitoring in the drug label.

IV Compatibility

There is limited information regarding the compatibility of Enalapril/ Felodipine and IV administrations.

Overdosage

There is limited information regarding Enalapril/ Felodipine overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.

Pharmacology

There is limited information regarding Enalapril/ Felodipine Pharmacology in the drug label.

Mechanism of Action

There is limited information regarding Enalapril/ Felodipine Mechanism of Action in the drug label.

Structure

There is limited information regarding Enalapril/ Felodipine Structure in the drug label.

Pharmacodynamics

There is limited information regarding Enalapril/ Felodipine Pharmacodynamics in the drug label.

Pharmacokinetics

There is limited information regarding Enalapril/ Felodipine Pharmacokinetics in the drug label.

Nonclinical Toxicology

There is limited information regarding Enalapril/ Felodipine Nonclinical Toxicology in the drug label.

Clinical Studies

There is limited information regarding Enalapril/ Felodipine Clinical Studies in the drug label.

How Supplied

There is limited information regarding Enalapril/ Felodipine How Supplied in the drug label.

Storage

There is limited information regarding Enalapril/ Felodipine Storage in the drug label.

Images

Drug Images

{{#ask: Page Name::Enalapril/ Felodipine |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

{{#ask: Label Page::Enalapril/ Felodipine |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Enalapril/ Felodipine Patient Counseling Information in the drug label.

Precautions with Alcohol

Alcohol-Enalapril/ Felodipine interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

There is limited information regarding Enalapril/ Felodipine Brand Names in the drug label.

Look-Alike Drug Names

There is limited information regarding Enalapril/ Felodipine Look-Alike Drug Names in the drug label.

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.